1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years.
N Engl J Med 2017;377(1):13-27.
2. Korean Society for the Study of Obesity (KSSO). 2019 Obesity Fact Sheet. Seoul: KSSO; 2019.
3. Lee CJ, Kim MJ, An SJ. Current treatments on obesity.
Korean J Health Promot 2019;19(4):171-85.
4. Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity.
Adv Nutr 2016;7(1):66-75.
5. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection.
Int J Obes (Lond) 2013;37(3):333-40.
6. Pasarica M, Dhurandhar NV. Infectobesity: obesity of infectious origin.
Adv Food Nutr Res 2007;52:61-102.
7. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids.
Int J Obes (Lond) 2005;29(3):281-6.
8. Mills S, Shanahan F, Stanton C, Hill C, Coffey A, Ross RP. Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota.
Gut Microbes 2013;4(1):4-16.
9. Bassols J, Moreno JM, Ortega F, Ricart W, Fernandez-Real JM. Characterization of herpes virus entry mediator as a factor linked to obesity.
Obesity (Silver Spring) 2010;18(2):239-46.
10. de Brito G, Lupinacci FC, Beraldo FH, Santos TG, Roffé M, Lopes MH, et al. Loss of prion protein is associated with the development of insulin resistance and obesity.
Biochem J 2017;474(17):2981-91.
12. Bianchi F, Duque ALRF, Saad SMI, Sivieri K. Gut microbiome approaches to treat obesity in humans.
Appl Microbiol Biotechnol 2019;103(3):1081-94.
13. Dhurandhar NV. Contribution of pathogens in human obesity.
Drug News Perspect 2004;17(5):307-13.
14. Dhurandhar NV, Bailey D, Thomas D. Interaction of obesity and infections.
Obes Rev 2015;16(12):1017-29.
15. Jang EJ, Baik HW, Park JS, Park SJ, Ryu JK, Park YM. The effect of Helicobacter pylori eradication on gastric ghrelin expression, appetite, and body mass index in patients with peptic ulcer. Cancer Prev Res 2005;10(1):29-33.
16. Del Fiol FS, Balcão VM, Barberato-Fillho S, Lopes LC, Bergamaschi CC. Obesity: a new adverse effect of antibiotics?
Front Pharmacol 2018;9:1408.
17. Tian Y, Jennings J, Gong Y, Sang Y. Viral infections and interferons in the development of obesity.
Biomolecules 2019;9(11):726.
18. Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren.
Int J Obes (Lond) 2010;34(1):89-93.
19. Atkinson RL, Lee I, Shin HJ, He J. Human adenovirus-36 antibody status is associated with obesity in children.
Int J Pediatr Obes 2010;5(2):157-60.
21. Voss JD, Dhurandhar NV. Viral infections and obesity.
Curr Obes Rep 2017;6(1):28-37.
22. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology.
Proc Natl Acad Sci U S A 2005;102(31):11070-5.
23. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest.
Nature 2006;444(7122):1027-31.
24. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice.
Science 2013;341(6150):1241214.
26. Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes.
Science 2018;359(6380):1151-6.
27. Kim JM. Roles of enteric microbial composition and metabolism in health and diseases.
Korean J Gastroenterol 2013;62(4):191-205.
28. Olesen SW, Alm EJ. Dysbiosis is not an answer.
Nat Microbiol 2016;1:16228.
31. Hicks LA, Taylor TH Jr, Hunkler RJ. U.S. outpatient antibiotic prescribing, 2010.
N Engl J Med 2013;368(15):1461-2.
32. Leong KSW, McLay J, Derraik JGB, Gibb S, Shackleton N, Taylor RW, et al. Associations of prenatal and childhood antibiotic exposure with obesity at age 4 years.
JAMA Netw Open 2020;3(1):e1919681.
34. Torres L, Martins VD, Faria AMC, Maioli TU. The intriguing relationship between obesity and infection.
J Infectiology 2018;1(1):6-10.
35. Tagliabue C, Principi N, Giavoli C, Esposito S. Obesity: impact of infections and response to vaccines.
Eur J Clin Microbiol Infect Dis 2016;35(3):325-31.
36. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection.
Int J Obes (Lond) 2013;37(3):333-40.
37. Green WD, Beck MA. Obesity impairs the adaptive immune response to influenza virus.
Ann Am Thorac Soc 2017;14(Supplement_5):S406-9.
38. Baik I, Curhan GC, Rimm EB, Bendich A, Willett WC, Fawzi WW. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women.
Arch Intern Med 2000;160(20):3082-8.
39. Anderin C, Gustafsson UO, Heijbel N, Thorell A. Weight loss before bariatric surgery and postoperative complications: data from the Scandinavian Obesity Registry (SOReg).
Ann Surg 2015;261(5):909-13.
40. Ashburn DD, DeAntonio A, Reed MJ. Pulmonary system and obesity.
Crit Care Clin 2010;26(4):597-602.
41. Dobner J, Kaser S. Body mass index and the risk of infection - from underweight to obesity.
Clin Microbiol Infect 2018;24(1):24-8.
42. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness : systematic review and meta-analysis.
BMJ 2013;347:f5061.
43. Milner JJ, Beck MA. Obesity and influenza infection severity.
Future Virol 2014;9(3):223-5.
44. Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1).
Clin Infect Dis 2011;52(3):301-12.
45. Honce R, Schultz-Cherry S. Impact of obesity on influenza A virus pathogenesis, immune response, and evolution.
Front Immunol 2019;10:1071.
47. Maier HE, Lopez R, Sanchez N, Ng S, Gresh L, Ojeda S, et al. obesity increases the duration of influenza A virus shedding in adults.
J Infect Dis 2018;218(9):1378-82.
48. Fernandez C, Manuel A. Obesity, respiratory disease and pulmonary infections.
Ann Res Hosp 2017;1(5):38.
49. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet 2020;395(10223):507-13.
52. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis.
Int J Infect Dis 2016;49:129-33.
54. Cha MA, Woo YR, Kim HJ, Kim MS, Ahn YH. Factors associated with obesity of acute bronchiolitis in infants: association of obesity with disease severity.
Allergy Asthma Respir Dis 2015;3(4):281-7.
55. Harpsøe MC, Nielsen NM, Friis-Møller N, Andersson M, Wohlfahrt J, Linneberg A, et al. Body mass index and risk of infections among women in the Danish national birth cohort.
Am J Epidemiol 2016;183(11):1008-17.
56. Kaspersen KA, Pedersen OB, Petersen MS, Hjalgrim H, Rostgaard K, Møller BK, et al. Obesity and risk of infection: results from the Danish blood donor study.
Epidemiology 2015;26(4):580-9.
58. Meijs AP, Koek MBG, Vos MC, Geerlings SE, Vogely HC, de Greeff SC. The effect of body mass index on the risk of surgical site infection.
Infect Control Hosp Epidemiol 2019;40(9):991-6.
59. Nseir W, Farah R, Mahamid M, Sayed-Ahmad H, Mograbi J, Taha M, et al. Obesity and recurrent urinary tract infections in premenopausal women: a retrospective study.
Int J Inf Dis 2015;41:32-5.
60. Cerdó T, García-Santos JA, G Bermúdez M, Campoy C. The role of probiotics and prebiotics in the prevention and treatment of obesity.
Nutrients 2019;11(3):635.
61. Huo L, Lyons J, Magliano DJ. Infectious and environmental influences on the obesity epidemic.
Curr Obes Rep 2016;5(3):375-82.
62. McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, et al. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway.
J Biol Chem 2009;284(46):31936-44.
63. Atamna A, Elis A, Gilady E, Gitter-Azulay L, Bishara J. How obesity impacts outcomes of infectious disease.
Eur J Clin Microbiol Infect Dis 2017;36(3):585-91.
65. Yadav H, Jain S, Nagpal R, Marotta F. Increased fecal viral content associated with obesity in mice.
World J Diabetes 2016;7(15):316-20.
66. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome.
Nature 2011;473(7346):174-80.